Sequence analysis of human rhinovirus aspirated from the nasopharynx of patients with relapsing-remitting MS

Abstract

Background

Upper respiratory infections were reported to trigger multiple sclerosis relapses. A relationship between picornavirus infections and MS relapses was recently reported.

Objective

To evaluate whether human rhinovirus is associated with multiple sclerosis relapses and whether any particular strain is predominant.

Method

Nasopharyngeal fluid was aspirated from 36 multiple sclerosis patients at pre-defined critical time points. Reverse-transcriptase-PCR was performed to detect human rhinovirus-RNA. Positive amplicons were sequenced.

Results

We found that rhinovirus RNA was present in 17/40 (43%) of specimens obtained at the onset of a URTI in 19 patients, in 1/21 specimens during convalescence after URTI in 14 patients, in 0/6 specimens obtained in 5 patients on average a week after the onset of an “at risk” relapse, occurring within a window in time from one week before to three weeks after an infection, and in 0/17 specimens obtained after the onset of a “not at risk” relapse not associated with any infection in 12 patients. Fifteen specimens from healthy control persons not associated with URTI were negative. The frequency of HRV presence in URTI was similar to that reported for community infections. Eight amplicons from patients represented 5 different HRV strains.

Conclusion

We were unable to reproduce previous findings of association between HRV infections and multiple sclerosis relapses. HRV was not present in nasopharyngeal aspirates obtained during “at risk” or “not at risk” relapses. Sequencing of HRV obtained from patients during URTI did not reveal any strain with predominance in multiple sclerosis.

Keywords

multiple sclerosis nasopharynx rhinovirus RNA upper respiratory tract infection

Get full access to this article

View all access options for this article.

References

1 Sibley W Bamford C Clark K . Clinical viral infections and multiple sclerosis. Lancet 1985; 1: 1313–1315.

2 Andersen O Lygner PE Bergström T Andersson M Vahlne A . Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 1993; 240: 417–422.

3 Panitch H . Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 1994; 36S: 25–28.

4 Edwards S Zvartau M Clarke H Irving W Blumhardt LD . Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper repiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 64: 736–741.

5 Buljevac D Flach HZ Hop WCJ . Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002; 125: 952–960.

6 Correale J Fiol M Gilmore W . The risk of relapses in multiple sclerosis during systemic infections. Neurology 2006; 67: 652–659.

7 Kriesel JD White A Hayden FG Spruance SL Petajan J . Multiple sclerosis attacks are associated with picorna virus infections. Mult Scler 2004; 10: 145–148.

8 Savolainen C Blomqvist S Mulders MN Hovi T . Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to enterovirus 70. J Gen Virol 2002; 83: 333–340.

9 Roussarie JP Ruffié C Brahic M . The role of myelin in Theiler’s virus persistence in the central nervous system. PLoS Pathog 2007; 3: e23.

10.

10 Salminen K Sadeharju K Lönnrot M . Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 2003; 69: 91–98.

11.

11 Nejentsev S Laaksonen M Tienari PJ . Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis. Hum Immunol 2003; 64: 345–349.

12.

12 Kostka T Praczko K . Interrelationship between physical activity, symptomatology of upper respiratory tract infections, and depression in elderly people. Gerontology 2007; 53: 187–193.

13.

13 Lönnrot M Sjöroos M Salminen K Maaronen M Hyypiä T Hyöty H . Diagnosis of enterovirus and rhinovirus infections by RT-PCR and time-resolved flurometry with lanthanide labeled probes. J Med Virol 1999; 59: 378–384.

14.

14 Berger MM Kopp N Vital C Redl B Aymard M Lina B . Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology 2000; 54: 20–25.

15.

15 Walker MP Schlaberg R Hays A Bowser R Lipkin I . Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients. Ann Neurol 2001; 49: 249–253.

16.

16 Xatzipsalti M Kyrana S Tsolla M . Rhinovirus viremia in children with respiratory infections. Am J Respir Crit Care Med 2005; 172: 1037–1040.

17.

17 Hendley JO . Clinical virology of rhinoviruses. Adv Virus Res 1999; 54: 453–466.

18.

18 Gwaltney JM Hendley JO Simon G Jordan WS . Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med 1966; 275: 1261–1268.

19.

19 Rihkanen H Carpén O Roivanen M Vaheri A Pitkäranta A . Rhinovirus in adenoid tissue. Int J Pediatr Otorhinolaryngol 2004; 68: 903–908.